NL-OMON50776已完成不适用
Inhalation of Low Molecular Weight Heparins as a prophylaxis to prevent SARS-CoV-2 infection - Nose-LMWH against COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy men and women between ages 18-65 with no medical history of
- •immunodeficiencies or chronic illness.
排除标准
- •COVID-19 in the volunteers medical history.
研究者
相似试验
尚未招募
1 期
Enriched heparin for the treatment of COVID-19RBR-7y8j2bsFaculdade de Medicina de Botucatu - UNESP
尚未招募
4 期
A study to determine effectiveness of Low Molecular Weight Heparin in reduction ofseverity of Acute PancreatitisCTRI/2022/12/048036Jawaharlal Institute of Postgraduate Medical Education and Research
进行中（未招募）
1 期
ow-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different dosesPrevention of thromboembolic events in hospitalised COVID-19 infected patientsMedDRA version: 20.0Level: HLGTClassification code 10014523Term: Embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersEUCTR2020-001709-21-FRCHRU de Nancy550
已完成
不适用
Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trialcolorectal cancerJPRN-UMIN000030582Tokyo Metropolitan Hiroo Hospital160
已完成
3 期
Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unitAcute respiratory distress syndrome.Acute respiratory distress syndromeIRCT20190506043492N4Ahvaz University of Medical Sciences60